Results
1 -
10 of
12
(Click
here to explore results)
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 12 Prodrugs in the Treatment of Viral Diseases. Michael J. Sofia
, 2013
, Pages 421-450
- Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 10 Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses. B. Mercorelli, A. Loregian
, 2022
, Pages 232-255
- Green Chemistry Strategies for Drug Discovery, Chapter 13 The Business Case for Green Chemistry in Drug Discovery. Joseph M. D. Fortunak, Martins O. Emeje, Harriet Kammendi, Ermias L. Tilahun, Xiang S. Wang
, 2015
, Pages 280-313
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Organophosphorus Chemistry: Volume 44, Chapter 5 Nucleotides and oligonucleotides: mononucleotides. Raman Narukulla, Yao-Zhong Xu
, 2015
, Volume 44
, Pages 170-192
- Macrocycles in Drug Discovery, CHAPTER 7 Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets. Wieslaw M. Kazmierski, Richard L. Jarvest, Jacob J. Plattner, Xianfeng Li
, 2015
, Pages 235-282
- Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 10 Development Programs for Oral Fixed Dose Combination Products. Patrick J. Crowley, Sharon M. Maglennon, Luigi G. Martini, David Templeton
, 2022
, Pages 259-286
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 6 Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. Ssang-Goo Cho, Claude Hughes, Iyer Mahalaxmi, Mohana Devi Subramaniam, Balachandar Vellingiri, Stafford Warren
, 2022
, Volume 1
, Pages 136-164